4893 items matching your search terms.

ANZ1001 SORBET: Study of estrogen receptor beta and efficacy of tamoxifen, a single arm, phase II study of the efficacy of tamoxifen in triple-negative but estrogen receptor beta-positive metastatic breast cancer

Phillips, KA Kiely, BE Francis, PA Boyle, FM Fox, SB Murphy, L Gebski, V Lindsay, DF Sutherland, RL Badger, HD Forbes, JF Australia and New Zealand Breast Cancer Trials Group,

NICU sepsis audit at Nepean hospital

Ponnampalam, G Shingde, V Gurnasinghania, S Martin, A Leroi, M Deshpande, G Downe, L

Lipid-modifying therapies and risk of pancreatitis: a meta-analysis

Preiss, D Tikkanen, MJ Welsh, P Ford, I Lovato, LC Elam, MB LaRosa, JC DeMicco, DA Colhoun, HM Goldenberg, I Murphy, MJ MacDonald, TM Pedersen, TR Keech, AC Ridker, PM Kjekshus, J Sattar, N McMurray, JJ

Lipid-modifying therapies and risk of pancreatitis: A meta-analysis

Preiss, D. Tikkanen, M. J. Welsh, P. Ford, I. Lovato, L. C. Elam, M. B. LaRosa, J. C. DeMicco, D. A. Colhoun, H. M. Goldenberg, I. Murphy, M. J. MacDonald, T. M. Pedersen, T. R. Keech, A. C. Ridker, P. M. Kjekshus, J. Sattar, N. McMurray, J. J. V.
JAMA - JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012     DOI:10.1001/jama.2012.8439

PTEN and advanced colorectal cancer: analysis from the phase III AGITG MAX trial of capecitabine alone or in combination with bevacizumab ± mitomycin C

Price, TJ Hardingham, J Lee, C Townsend, A Wrin, J Wilson, K Weickhardt, AJ Simes, J Murone, C Tebbutt, NC

Analysis of PTEN in patients with advanced colorectal cancer receiving capecitabine alone or in combination with bevacizumab ± mitomycin C in the phase III AGITG MAX trial

Price, TJ Hardingham, J Lee, C Wrin, J Townsend, AR Wilson, K Weickhardt, AJ Simes, J Murone, C Tebbutt, NC

Final results of Australasian Gastro-Intestinal Trials Group (AGITG) ARCTIC study: an international audit of raltitrexed for patients with cardiac toxicity induced by fluoropyrimidines

Price, T Wilson, K Simes, RJ Yip, D Karapetis, CS Tebbutt, NC Gebski, V Fournier, M Ferry, DR Ransom, D

Bevacizumab is equally effective and no more toxic in elderly patients with advanced colorectal cancer: a subgroup analysis from the AGITG MAX trial: an international randomised controlled trial of capecitabine, bevacizumab and mitomycin C

Price, TJ Zannino, D Wilson, K Simes, J Cassidy, J Van Hazel, GA Robinson, BA Broad, A Ganju, V Ackland, SP Tebbutt, NC
ANNALS OF ONCOLOGY, 2012     DOI:10.1093/annonc/mdr488

Flow-mediated dilatation assessment in women with preeclampsia compared to women with gestational hypertension

Quinton, A. E. Peek, M. J. Cook, C. M. Kirby, A.
HYPERTENSION IN PREGNANCY, 2012     DOI:10.3109/10641955.2010.525282

Cellular detection of multiple antigens at single cell resolution using antibodies generated from the same species

Ranjan, AK Joglekar, MV Atre, AN Patole, M Bhonde, RR Hardikar, AA

Simultaneous imaging of microRNA or mRNA territories with protein territory in mammalian cells at single cell resolution

Ranjan, AK Joglekar, MV Atre, AN Patole, M Bhonde, RR Hardikar, AA
RNA BIOLOGY, 2012     DOI:10.4161/rna.20484

Results of Australasian Gastrointestinal Trials Group (AGITG) Arctic study: An international audit of raltitrexed for patients with cardiac toxicity induced by fluoropyrimidines

Ransom, D Wilson, K Bishnoi, SK Simes, J Yip, D Karapetis, CS Gebski, V Gordon, S Fournier, M Ferry, DR Abbas, H Midgley, RA Price, TJ

Final results of Australasian Gastro-Intestinal Trials Group ARCTIC study – an international audit of raltitrexed for patients with cardiac toxicity induced by fluoropyrimidines

Ransom, D Wilson, K Simes, J Yip, D Tebbutt, N Karapetis, C. Fournier, M Ferry, D Price, T.

CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the breast international group 1-98 trial

Regan, MM Leyland-Jones, B Bouzyk, M Pagani, O Tang, W Kammler, R Dell'orto, P Biasi, MO Thürlimann, B Lyng, MB Ditzel, HJ Neven, P Debled, M Maibach, R Price, KN Gelber, RD Coates, AS Goldhirsch, A Rae, JM Viale, G Breast International Group (BIG) 1-98 Collaborative Group,
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2012     DOI:10.1093/jnci/djs125

Subjective cognitive complaints one year after ceasing adjuvant endocrine treatment for early-stage breast cancer

Ribi, K Aldridge, J Phillips, KA Thompson, A Harvey, V Thürlimann, B Cardoso, F Pagani, O Coates, AS Goldhirsch, A Price, KN Gelber, RD Bernhard, J BIG 1-98 Collaborative Group, International Breast Cancer Study Group,
BRITISH JOURNAL OF CANCER, 2012     DOI:10.1038/bjc.2012.156